Evidence map›Paper›PMID 19028679›Full record

ArticleThe Journal of biological chemistry2009

Proteasomal protein degradation in Mycobacteria is dependent upon a prokaryotic ubiquitin-like protein.

Kristin E Burns, Wei-Ting Liu, Helena I M Boshoff, Pieter C Dorrestein, Clifton E Barry

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 142 citations in OpenAlex.

  1. Review
  2. Assessment of Bacterial N-Degron Proteolysis by a Dual-Fluorescence Reporter.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Future Research Directions on Mycobacterium tuberculosis Proteins.Advances in experimental medicine and biology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Identification of a depupylation regulator for an essential enzyme inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Control of Toxin-Antitoxin Systems by Proteases inFrontiers in molecular biosciences · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kristin E BurnsTuberculosis Research Section, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Wei-Ting LiuDepartments of Pharmacology, Chemistry, and Biochemistry, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093.
Helena I M BoshoffTuberculosis Research Section, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Pieter C DorresteinDepartments of Pharmacology, Chemistry, and Biochemistry, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093.
Clifton E BarryTuberculosis Research Section, NIAID, National Institutes of Health, Bethesda, Maryland 20892. Electronic address: cbarry@mail.nih.gov.
University of California, San Diego · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Exploring the metabolism of non-replicating and drug-resistant TBZIAAI000783 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2009 to 2017
$8.2M
Pathogenesis, Latency and Drug Resistance Of Mycobacterium TuberculosisZ01AI000783 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI BARRY, CLIFTON · 1997 to 2008
$5.8M
Intramural NIH HHS Z01 AI000783
6 · The paper itself

Abstract

The striking identification of an apparent proteasome core in Mycobacteria and allied actinomycetes suggested that additional elements of this otherwise strictly eukaryotic system for regulated protein degradation might be conserved. The genes encoding this prokaryotic proteasome are clustered in an operon with a short open reading frame that encodes a small protein of 64 amino acids resembling ubiquitin with a carboxyl-terminal di-glycine-glutamine motif (herein called Pup for prokaryotic ubiquitin-like protein). Expression of a polyhistidine-tagged Pup followed by pulldown revealed that a broad spectrum of proteins were post-translationally modified by Pup. Two-dimensional gel electrophoresis allowed us to conclusively identify two targets of this modification as myoinositol-1-phosphate synthase and superoxide dismutase. Deletion of the penultimate di-glycine motif or the terminal glutamine completely abrogated modification of cellular proteins with Pup. Further mass spectral analysis demonstrated that Pup was attached to a lysine residue on its target protein via the carboxyl-terminal glutamine with deamidation of this residue. Finally, we showed that cell lysates of wild type (but not a proteasome mutant) efficiently degraded Pup-modified proteins. These data therefore establish that, despite differences in both sequence and target linkage, Pup plays an analogous role to ubiquitin in targeting proteins to the proteasome for degradation.

Indexed as

Amino Acid SequenceBacterial ProteinsBase SequenceDNA PrimersElectrophoresis, Gel, Two-DimensionalElectrophoresis, Polyacrylamide GelHydrolysisMolecular Sequence DataMycobacterium smegmatisProteasome Endopeptidase ComplexSequence Homology, Amino AcidSubstrate SpecificityTandem Mass SpectrometryUbiquitinBacterial ProteinsDNA PrimersProteasome Endopeptidase ComplexUbiquitin

Identifiers

PMID19028679
PMCPMC2631945
OpenAlexW1994526268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.